Partnering for Innovation

We value external innovation Complementing our internal innovation and expertise AGREEMENTS ENTERED IN: Oncology Immunology 8 Product out-licensing agreements and divestments Ophthalmology Gene therapy Neurology Technology platforms PHC Rare diseases 9 Agreements derived from existing alliances 13 PHC agreements 1 Acquisition Roche 60 NEW AGREEMENTS in 2021 15 Product, technology or discovery license agreements 14 Research and discovery collaborations

View entire presentation